Value of SPECT/CT in Diagnostic I-131 MIBG Scintigraphy in Patients with Neuroblastoma
10.1007/s13139-018-0532-y
- Author:
Daris THEERAKULPISUT
1
;
Yutapong RARUENROM
;
Nantaporn WONGSURAWAT
;
Charoonsak SOMBOONPORN
Author Information
1. Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Khon Kaen University, 123 Mittraparp highway, Muang, Khon Kaen 40002, Thailand. daris.th@gmail.com yutapongkku@gmail.com dr.nantaporn@gmail.com charoonsak.som@gmail.com
- Publication Type:Original Article
- Keywords:
Diagnostic I-131 MIBG scintigraphy;
MIBG;
Neuroblastoma;
Radionuclide imaging;
SPECT/CT
- MeSH:
3-Iodobenzylguanidine;
Diagnosis;
Humans;
Neuroblastoma;
Radionuclide Imaging;
Retrospective Studies
- From:Nuclear Medicine and Molecular Imaging
2018;52(5):350-358
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Diagnostic I-131 MIBG scintigraphy is an important imaging modality for evaluation of patients with neuroblastoma (NB) especially in centers where I-123 MIBG is not available. Single photon emission computed tomography/computed tomography (SPECT/CT) could potentially improve lesion detection over planar scintigraphy, but studies regarding its usefulness as an add-on to diagnostic I-131 MIBG scintigraphy are limited. This study aimed to determine the usefulness and factors related to usefulness of SPECT/CT in diagnostic I-131 MIBG scintigraphy in NB patients.METHODS: Usefulness of SPECT/CT for lesion detection, lesion localization, resolving suspicious findings, and clarifying the nature of lesions on anatomical imaging were retrospectively reviewed in 86 diagnostic planar I-131 MIBG scintigrams with add-on SPECT/CT.RESULTS: SPECT/CT detected additional lesions in 23.2%(20/86), helped localize lesions in 21.1%(8/38), resolved suspicious findings in 85.7%(6/7), determined functional status of lesions on anatomical imaging in 94.4%(17/18), and changed diagnosis from a negative to a positive study in 19.5%(8/41). Independent predictors of SPECT/CT being useful included presence of suspicious findings on planar imaging (OR 99.08; 95% C.I. 6.99–1404.41; p = 0.001), positive findings on planar imaging (OR 4.61; 95% C.I. 1.05, 20.28; p < 0.001), and presence of structural lesions on anatomical imaging (OR 32.54; 95% C.I. 5.37–196.96; p < 0.001).CONCLUSION: SPECT/CT is a useful add-on to diagnostic planar I-131 MIBG scintigraphy. Predictors of usefulness of SPECT/CT include suspicious or positive findings on planar scintigraphy and the presence of structural lesions on anatomical imaging.
